ARQ, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.96 USD | +1.46% |
|
-2.93% | -.--% |
| May. 15 | Arq, Inc. announced that it expects to receive $15.000006 million in funding | CI |
| May. 09 | Transcript : Arq, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 58% by 2026.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -.--% | 251M | C | ||
| +2.46% | 102B | A- | ||
| -8.98% | 60.79B | A- | ||
| +74.76% | 48.86B | B | ||
| +13.97% | 37.96B | B | ||
| +4.56% | 32.37B | A- | ||
| +14.72% | 20.64B | B- | ||
| +11.17% | 16.58B | C+ | ||
| +8.81% | 13.93B | B- | ||
| -3.19% | 13.25B | B |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
- Stock Market
- Equities
- ARQ Stock
- Ratings Arq, Inc.
